Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Creating a safe, private environment and focusing on a patient-centered approach allows dental professionals to effectively address sensitive topics, like GLP-1 medications and their potential physical, psychological, and emotional impacts on patients
This occurs due to the medications ability to diminish glucagon release, thereby aiding in decreasing blood sugar levels and influencing urination patterns
Additionally, patients receiving GLP-1 medications often have metabolic conditions that independently affect cancer risk, making it challenging to isolate drug effects
Lancet 368:1869
US$ 20.64
US$ 27.37
US$ 27.37
US$ 22.45
